<DOC>
	<DOC>NCT01634230</DOC>
	<brief_summary>This study is in patients with acute liver failure who are not responding to standard of care.</brief_summary>
	<brief_title>Emergency Use of OCR-002 in Acute Liver Failure</brief_title>
	<detailed_description>This is an open-label study in patients diagnosed with ALF who are not responding to the institution's standards of care. Standard of care may include, but is not limited to, administration of N-acetylcysteine, lactulose, hypothermia therapy, and consideration for orthotopic liver transplant. Outcome measures are safety and decrease in ammonia levels.</detailed_description>
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Liver Failure, Acute</mesh_term>
	<mesh_term>Phenylacetic acid</mesh_term>
	<criteria>International Normalized Ratio (INR) ≥1.5 with encephalopathy in patient with no prior history of liver disease Venous ammonia level of ≥ 100 μmol/L Patients who are pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>